Literature DB >> 20530230

Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma.

Lorena Baietto1, Antonio D'Avolio, Giusi Ventimiglia, Francesco Giuseppe De Rosa, Marco Siccardi, Marco Simiele, Mauro Sciandra, Giovanni Di Perri.   

Abstract

We have developed and validated a high-performance liquid chromatography method coupled with a mass detector to quantify itraconazole, voriconazole, and posaconazole using quinoxaline as the internal standard. The method involves protein precipitation with acetonitrile. Mean accuracy (percent deviation from the true value) and precision (relative standard deviation percentage) were less than 15%. Mean recovery was more than 80% for all drugs quantified. The lower limit of quantification was 0.031 microg/ml for itraconazole and posaconazole and 0.039 microg/ml for voriconazole. The calibration range tested was from 0.031 to 8 microg/ml for itraconazole and posaconazole and from 0.039 to 10 microg/ml for voriconazole.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20530230      PMCID: PMC2916319          DOI: 10.1128/AAC.01807-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  44 in total

1.  Direct injection HPLC micro method for the determination of voriconazole in plasma using an internal surface reversed-phase column.

Authors:  F Péhourcq; C Jarry; B Bannwarth
Journal:  Biomed Chromatogr       Date:  2004-11       Impact factor: 1.902

Review 2.  Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry.

Authors:  Paul J Taylor
Journal:  Clin Biochem       Date:  2005-04       Impact factor: 3.281

3.  Isocratic high-performance liquid chromatographic method with ultraviolet detection for simultaneous determination of levels of voriconazole and itraconazole and its hydroxy metabolite in human serum.

Authors:  GholamAli Khoschsorur; Franz Fruehwirth; Sieglinde Zelzer
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

4.  A sensitive liquid chromatography and mass spectrometry method for the determination of posaconazole in human plasma.

Authors:  Jim X Shen; Gopal Krishna; Roger N Hayes
Journal:  J Pharm Biomed Anal       Date:  2006-07-21       Impact factor: 3.935

5.  Determination of itraconazole in human plasma by high-performance liquid chromatography with solid-phase extraction.

Authors:  Tadashi Ohkubo; Takako Osanai
Journal:  Ann Clin Biochem       Date:  2005-03       Impact factor: 2.057

6.  A rapid HPLC method with fluorometric detection for determination of plasma itraconazole and hydroxy-itraconazole concentrations in cystic fibrosis children with allergic bronchopulmonary aspergillosis.

Authors:  Stefanie Redmann; Bruce G Charles
Journal:  Biomed Chromatogr       Date:  2006-04       Impact factor: 1.902

7.  Simultaneous quantification of voriconazole and posaconazole in human plasma by high-performance liquid chromatography with ultra-violet detection.

Authors:  Stéphanie Chhun; Elisabeth Rey; Agnes Tran; Olivier Lortholary; Gérard Pons; Vincent Jullien
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-02-01       Impact factor: 3.205

8.  Variability of voriconazole plasma levels measured by new high-performance liquid chromatography and bioassay methods.

Authors:  Andres Pascual; Valérie Nieth; Thierry Calandra; Jacques Bille; Saskia Bolay; Laurent A Decosterd; Thierry Buclin; Paul A Majcherczyk; Dominique Sanglard; Oscar Marchetti
Journal:  Antimicrob Agents Chemother       Date:  2006-11-06       Impact factor: 5.191

9.  Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.

Authors:  Andres Pascual; Thierry Calandra; Saskia Bolay; Thierry Buclin; Jacques Bille; Oscar Marchetti
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

10.  Measurement of voriconazole in serum and plasma.

Authors:  Loralie J Langman; Felix Boakye-Agyeman
Journal:  Clin Biochem       Date:  2007-08-16       Impact factor: 3.281

View more
  7 in total

1.  Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspofungin.

Authors:  Laurent Arthur Decosterd; Bertrand Rochat; Benoît Pesse; Thomas Mercier; Frédéric Tissot; Nicolas Widmer; Jacques Bille; Thierry Calandra; Boris Zanolari; Oscar Marchetti
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

2.  Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children.

Authors:  Sarah Allegra; Giovanna Fatiguso; Silvia De Francia; Fabio Favata; Elisa Pirro; Chiara Carcieri; Amedeo De Nicolò; Jessica Cusato; Giovanni Di Perri; Antonio D'Avolio
Journal:  Br J Clin Pharmacol       Date:  2017-09-24       Impact factor: 4.335

3.  A simple high-performance liquid chromatography method for simultaneous determination of three triazole antifungals in human plasma.

Authors:  Mei Zhang; Grant A Moore; Murray L Barclay; Evan J Begg
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

4.  Development and Validation of Voriconazole Concentration by LC-MS-MS: Applied in Clinical Implementation.

Authors:  Santirat Prommas; Apichaya Puangpetch; Nuttawut Jenjirattithigarn; Sumonrat Chuwongwattana; Thawinee Jantararoungtong; Napatrupron Koomdee; Siwalee Santon; Montri Chamnanphon; Chonlaphat Sukasem
Journal:  J Clin Lab Anal       Date:  2016-06-24       Impact factor: 2.352

5.  Analysis of imidazoles and triazoles in biological samples after MicroExtraction by packed sorbent.

Authors:  Cristina Campestre; Marcello Locatelli; Paolo Guglielmi; Elisa De Luca; Giuseppe Bellagamba; Sergio Menta; Gokhan Zengin; Christian Celia; Luisa Di Marzio; Simone Carradori
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

Review 6.  Assessment of greenness for the determination of voriconazole in reported analytical methods.

Authors:  Hemanth Kumar Chanduluru; Abimanyu Sugumaran
Journal:  RSC Adv       Date:  2022-02-28       Impact factor: 3.361

7.  Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection.

Authors:  Sarah Allegra; Giovanna Fatiguso; Silvia De Francia; Fabio Favata; Elisa Pirro; Chiara Carcieri; Amedeo De Nicolò; Jessica Cusato; Giovanni Di Perri; Antonio D'Avolio
Journal:  Biomedicines       Date:  2017-11-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.